NCT04739592View on ClinicalTrials.gov

A Study of Alendronate Sodium Vitamin D3 Tablets on Knee Osteoarthritis

PHASE4UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2024

Conditions
Knee Osteoarthritis
Interventions
DRUG

alendronate sodium vitamin D3 tablets

once per week for one year

DRUG

Placebo

once per week for one year

Trial Locations (3)

Unknown

RECRUITING

Peking Union Medical College Hospital, Beijing

RECRUITING

The Third Affiliated Hospital of Southern Medical University, Guangzhou

RECRUITING

Zhongshan Hospital, Shanghai

Sponsors
All Listed Sponsors
collaborator

CSPC Ouyi Pharmaceutical Co., Ltd.

INDUSTRY

lead

Peking Union Medical College Hospital

OTHER

NCT04739592 - A Study of Alendronate Sodium Vitamin D3 Tablets on Knee Osteoarthritis | Biotech Hunter | Biotech Hunter